Saturday, December 08, 2007

Front-line AIDS drugs show staying power: study

From AFP:
Standard triple-drug treatment for HIV provides long-term protection against the development of full-blown AIDS, according to a study released Friday.

But when this front-line therapy fails, HIV-infected people in poorer nations could find themselves nearly defenceless against AIDS-related disease, it warned.

Data on 7,916 HIV-infected individuals in Britain who began standard triple-drug therapy showed that only 167 developed extensive resistance to all three types of medication, the researchers found.

The risk of such "triple-class" failure at the end of 10 years was estimated at 9.2 percent, according the study, published in the British medical journal The Lancet. ...more

No comments: